In Annex II, the Community list entry on Foeniculum vulgare Miller subsp. vulgare var. vulgare, fructus and the Community list entry on Foeniculum vulgare Miller subsp. vulgare var. dulce (Miller) Thellung, fructus are replaced by the following:
Foeniculum vulgare Miller subsp. vulgare var. vulgare
Apiaceae
Bitter fennel, fruit
BG (bulgarski): Горчиво резене, плод | LT (lietuvių kalba): Kartieji pankolių, vaisiai
CS (čeština): Plod fenyklu obecného pravého | LV (latviešu valoda): Rūgtā fenheļa, augļi
DA (dansk): Fennikel bitter | MT (malti): Bużbież morr, frotta
DE (Deutsch): Bitterer Fenchel | NL (nederlands): Bittere venkel, vrucht
EL (elliniká): Πικρού μάραθου καρπός | PL (polski): Koper włoski odmiany gorzkiej, owoc
EN (English): Bitter Fennel | PT (português): Funcho-amargo, fruto
ES (español): Hinojo amargo, fruto | RO (română): Fenicul amar, fruct
ET (eesti keel): Mõru apteegitill, vili | SK (slovenčina): Plod fenikla horkého
FI (suomi): Karvasfenkoli, hedelmä | SL (slovenščina): Plod grenkega navadnega komarčka
FR (français): Fenouil amer, fruit | SV (svenska): Bitterfänkål, frö
HR (hrvatski): Komorač gorki, plod | IS (íslenska): Bitur fennel aldin
HU (magyar): Keserű édeskömény, termés | NO (norsk): Bitter fennikel
IT (italiano): Finocchio amaro, frutto |
Not applicable
Bitter fennel – Foeniculi amari fructus (04/2013:0824)
Indication (1)
Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence.
Indication (2)
Traditional herbal medicinal product for symptomatic treatment of minor spasm associated with menstrual periods.
Indication (3)
Traditional herbal medicinal product used as an expectorant in cough associated with cold.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
European
Please see “Specified posology”
Indications (1) and (3)
Single dose
Herbal tea: 1,5 g of herbal substance in 250 ml of boiling water (steep for 15 minutes) as a herbal infusion, 3 times daily.
Recommended daily dose: 4,5 g
Single dose
Herbal tea: 1,0 g of herbal substance in 100 ml of boiling water (steep for 15 minutes) as a herbal infusion, 3 times daily.
Recommended daily dose: 3,0 g
For further information on the use in children between 4 and 12 years of age, see section “Special warnings and precautions for use”.
The use is not recommended in children under 4 years of age (see section “Special warnings and precautions for use”).
See section “Pharmaceutical particulars” for content of estragole.
Indication (2)
Single dose
Herbal tea: 1,5 g of herbal substance in 250 ml of boiling water (steep for 15 minutes) as a herbal infusion, 3 times daily.
Recommended daily dose: 4,5 g
The use in children under 12 years of age is not recommended (see section “Special warnings and precautions for use”).
See section “Pharmaceutical particulars” for content of estragole.
Oral use
Indications (1), (2) and (3)
Not to be taken for more than 2 weeks.
Indications (1) and (3)
For short-term use in mild transitory symptoms only (less than one week).
If the symptoms persist during the use of the medicinal product, a doctor or a qualified health-care practitioner should be consulted.
Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) family (aniseed, caraway, celery, coriander and dill) or to anethole.
Hypersensitivity to mugwort pollen, due to cross-reactivity with fennel.
Indications (1) and (3)
The use in children between 4 and 12 years of age is not recommended if the daily intake of estragole exceeds the guidance value of 1,0 μg/kg bw, unless justified by a risk assessment based on adequate safety data.
The use is not recommended in children under 4 years of age due to the lack of adequate data.
Indication (2)
The use in children under 12 years of age has not been established due to lack of adequate data.
If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
None reported
Safety during pregnancy and lactation has not been established.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
There is evidence that trans-anethole is excreted in human breast milk.
No fertility data available.
No studies on the effect on the ability to drive and use machines have been performed.
Allergic reactions to fennel, affecting the skin or the respiratory system, may occur. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or a qualified health-care practitioner should be consulted.
No case of overdose has been reported.
In the general population exposure to estragole should be kept as low as practically achievable.
In pregnant and breast-feeding women, the daily intake of estragole should be below 0,05 mg/person per day.
In children below 12 years of age, the daily intake of estragole should be below 1,0 μg/kg bw.
For further details see the “Public statement on the use of herbal medicinal products containing estragole”*.
Not applicable.
* “Public statement on the use of herbal medicinal products containing estragole” of 12 May 2023 of the Committee on Herbal Medicinal Products, EMA/HMPC/137212/2005, Rev 1 Corr 1, available at: https://www.ema.europa.eu/en/documents/other/public-statement-use-herbal-medicinal-products-containing-estragole-revision-1_en.pdf.
Foeniculum vulgare Miller subsp. vulgare var. dulce (Mill.) Batt. & Trab.
Apiaceae
Sweet fennel, fruit
BG (bulgarski): Сладко резене, плод | LT (lietuvių kalba): Saldieji pankolių, vaisiai
CS (čeština): Plod fenyklu obecného sladkého | LV (latviešu valoda): Saldā fenheļa, augļi
DA (dansk): Fennikel sød | MT (malti): Bużbież ħelu, frotta
DE (Deutsch): Süßer Fenchel | NL (nederlands): Zoete venkel, vrucht
EL (elliniká): Γλυκού μάραθου καρπός | PL (polski): Koper włoski odmiany słodkiej, owoc
EN (English): Sweet fennel, fruit | PT (português): Funcho-doce, fruto
ES (español): Hinojo dulce, fruto | RO (română): Fenicul dulce, fruct
ET (eesti keel): Magus apteegitill, vili | SK (slovenčina): Plod fenikla sladkého
FI (suomi): Makeafenkoli, hedelmä | SL (slovenščina): Plod sladkega navadnega komarčka
FR (français): Fenouil doux, fruit | SV (svenska): Sötfänkål, frö
HR (hrvatski): Komorač slatki, plod | IS (íslenska): Sæt fennel aldin
HU (magyar): Édeskömény termés | NO (norsk): Søt fennikel
IT (italiano): Finocchio dolce, frutto |
Not applicable
Sweet fennel – Foeniculi dulcis fructus (04/2011:0825))
Indication (1)
Traditional herbal medicinal product for symptomatic treatment of mild, spasmodic gastro-intestinal complaints including bloating and flatulence.
Indication (2)
Traditional herbal medicinal product for symptomatic treatment of minor spasm associated with menstrual periods.
Indication (3)
Traditional herbal medicinal product used as an expectorant in cough associated with cold.
The product is a traditional herbal medicinal product for use in specified indications exclusively based upon long-standing use.
European
Please see “Specified posology”
Indications (1) and (3)
Single dose
Herbal tea: 1,5 g of herbal substance in 250 ml of boiling water (steep for 15 minutes) as a herbal infusion, 3 times daily.
Recommended daily dose: 4,5 g
Single dose
Herbal tea: 1,0 g of herbal substance in 100 ml of boiling water (steep for 15 minutes) as a herbal infusion, 3 times daily.
Recommended daily dose: 3,0 g
For further information on the use in children between 4 and 12 years of age, see section “Special warnings and precautions for use”.
The use is not recommended in children under 4 years of age (see section “Special warnings and precautions for use”).
See section “Pharmaceutical particulars” for content of estragole.
Indication (2)
Single dose
Herbal tea: 1,5 g of herbal substance in 250 ml of boiling water (steep for 15 minutes) as a herbal infusion, 3 times daily.
Recommended daily dose: 4,5 g
The use in children under 12 years of age is not recommended (see section “Special warnings and precautions for use”).
See section “Pharmaceutical particulars” for content of estragole.
Oral use
Indications (1), (2) and (3)
Not to be taken for more than 2 weeks.
Indications (1) and (3)
For short-term use in mild transitory symptoms only (less than one week).
If the symptoms persist during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
Hypersensitivity to the active substance or to Apiaceae (Umbelliferae) family (aniseed, caraway, celery, coriander and dill) or to anethole.
Hypersensitivity to mugwort pollen, due to cross-reactivity with fennel.
Indications (1) and (3)
The use in children between 4 and 12 years of age is not recommended if the daily intake of estragole exceeds the guidance value of 1,0 μg/kg bw, unless justified by a risk assessment based on adequate safety data.
The use is not recommended in children under 4 years of age due to the lack of adequate data.
Indication (2)
The use in children under 12 years of age has not been established due to lack of adequate data.
If the symptoms worsen during the use of the medicinal product, a doctor or a qualified health care practitioner should be consulted.
None reported
Safety during pregnancy and lactation has not been established.
In the absence of sufficient data, the use during pregnancy and lactation is not recommended.
There is evidence that trans-anethole is excreted in human breast milk.
No fertility data available.
No studies on the effect on the ability to drive and use machines have been performed.
Allergic reactions to fennel, affecting the skin or the respiratory system, may occur. The frequency is not known.
If other adverse reactions not mentioned above occur, a doctor or a qualified health-care practitioner should be consulted.
No case of overdose has been reported.
In the general population exposure to estragole should be kept as low as practically achievable.
In pregnant and breast-feeding women, the daily intake of estragole should be below 0,05 mg/person per day.
In children below 12 years of age, the daily intake of estragole should be below 1,0 μg/kg bw.
For further details see the “Public statement on the use of herbal medicinal products containing estragole”*.
Not applicable.
* “Public statement on the use of herbal medicinal products containing estragole” of 12 May 2023 of the Committee on Herbal Medicinal Products, (HMPC) EMA/HMPC/137212/2005, Rev 1 Corr 1, available at: https://www.ema.europa.eu/en/documents/other/public-statement-use-herbal-medicinal-products-containing-estragole-revision-1_en.pdf.’.